BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25771213)

  • 1. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013.
    Soliman AM; Yang H; Du EX; Kelkar SS; Winkel C
    Am J Obstet Gynecol; 2015 Aug; 213(2):141-60. PubMed ID: 25771213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic impact of uterine fibroids in the United States: a summary of published estimates.
    Mauskopf J; Flynn M; Thieda P; Spalding J; Duchane J
    J Womens Health (Larchmt); 2005 Oct; 14(8):692-703. PubMed ID: 16232101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The direct and indirect costs associated with endometriosis: a systematic literature review.
    Soliman AM; Yang H; Du EX; Kelley C; Winkel C
    Hum Reprod; 2016 Apr; 31(4):712-22. PubMed ID: 26851604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care resource use for uterine fibroid tumors in the United States.
    Flynn M; Jamison M; Datta S; Myers E
    Am J Obstet Gynecol; 2006 Oct; 195(4):955-64. PubMed ID: 16723104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
    Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
    J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
    Goldberg J; Bussard A; McNeil J; Diamond J
    Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estimated annual cost of uterine leiomyomata in the United States.
    Cardozo ER; Clark AD; Banks NK; Henne MB; Stegmann BJ; Segars JH
    Am J Obstet Gynecol; 2012 Mar; 206(3):211.e1-9. PubMed ID: 22244472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost to perform uterine fibroid embolisation in the Australian public hospital system.
    Clements W; Moriarty HK; Koukounaras J; Joseph T; Phan T; Goh GS
    J Med Imaging Radiat Oncol; 2020 Feb; 64(1):18-22. PubMed ID: 31793208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
    Becker ER
    J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the total costs of surgical treatment for uterine fibroids?
    Carls GS; Lee DW; Ozminkowski RJ; Wang S; Gibson TB; Stewart E
    J Womens Health (Larchmt); 2008 Sep; 17(7):1119-32. PubMed ID: 18687032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.
    Badiani B; Chiumente M; Messori A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():84-88. PubMed ID: 29408752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.
    Cain-Nielsen AH; Moriarty JP; Stewart EA; Borah BJ
    J Comp Eff Res; 2014 Sep; 3(5):503-14. PubMed ID: 24878319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
    Farquhar C; Brown PM; Furness S
    BJOG; 2002 Nov; 109(11):1273-80. PubMed ID: 12452466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
    Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
    J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual costs associated with diagnosis of uterine leiomyomata.
    Hartmann KE; Birnbaum H; Ben-Hamadi R; Wu EQ; Farrell MH; Spalding J; Stang P
    Obstet Gynecol; 2006 Oct; 108(4):930-7. PubMed ID: 17012456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.